UBS Aktienanleihe PHI1 18.12.2024/ DE000UBS03H2 /
04/06/2024 17:46:55 | Var.+0.020 | Denaro- | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
100.040EUR | +0.02% | - Quantità in denaro: - |
- Quantità in lettera: - |
KONINKL. PHILIPS EO ... | 12.129 EUR | 18/12/2024 | Call |
GlobeNewswire
22:10
ROSEN, A TOP RANKED LAW FIRM, Encourages Toyota Motor Corporation Investors to Inquire About Securit...
GlobeNewswire
22:10
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
GlobeNewswire
22:05
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
GlobeNewswire
22:05
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewswire
22:05
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja Ca...
GlobeNewswire
22:05
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
GlobeNewswire
22:05
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market in...
GlobeNewswire
22:05
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment o...
GlobeNewswire
22:05
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
22:05
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
Newsfile Corp
22:02
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cambium Networks Corporation Investors to Secure Counsel...
GlobeNewswire
22:01
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:01
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)